← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Alcamena Stem Cell Therapeutics, Llc
Baltimore, MD
$11,130,808
Total funding
5
Grants
Funding over time
peak $5.6M · FY2018–25$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$8,149,963 · 2
NIH$2,980,845 · 3
By mechanism
—$8,149,963 · 2
R44$1,500,000 · 1
R43$1,480,845 · 2
Investigators at Alcamena Stem Cell Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
FINAL-STAGE PRECLINICAL DEVELOPMENT OF A LONG-ACTING, NON-OPIOID PEPTIDOMIMETIC DRUG FOR CHRONIC PAIN$5,599,963
· FY2022 · Defense Health Agency
A NEW DRUG MODALITY TO RESTORE COGNITIVE AND PSYCHOLOGICAL HEALTH AFTER TRAUMATIC BRAIN INJURY$2,550,000
· FY2025 · Defense Health Agency
FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain$1,500,000
R44 · FY2025 · NS
OPTIMIZATION AND ASSESSMENT OF A BIOLOGIC TO IMPROVE COGNITIVE FUNCTION AFTER TRAUMATIC BRAIN INJURY$543,500
R43 · FY2019 · NS
OPTIMIZATION AND ASSESSMENT OF A BIOLOGIC TO IMPROVE FUNCTIONAL RECOVERY AFTER PERIPHERAL NERVE INJURY$389,350
R43 · FY2020 · NS
OPTIMIZATION AND ASSESSMENT OF A BIOLOGIC TO IMPROVE FUNCTIONAL RECOVERY AFTER PERIPHERAL NERVE INJURY$310,191
R43 · FY2019 · NS
OPTIMIZATION AND ASSESSMENT OF A BIOLOGIC TO IMPROVE COGNITIVE FUNCTION AFTER TRAUMATIC BRAIN INJURY$237,804
R43 · FY2018 · NS